January 20, 2026 · Form 4 insider transaction
QUAY STEVEN C bought 950,000 shares of Atossa Therapeutics, Inc. at $0.60 per share, a transaction worth $572.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The options shall vest on a quarterly basis over 24 months following January 20, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued on January 20, 2026, with an exercise price of $0.603, representing the closing stock price on January 20, 2026.